Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $139.36 (market cap $10.71B), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is far larger — about 2.8× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (4,332,079 versus 1,680,425). Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| FORM | RLAY | |
|---|---|---|
Market Cap | $10.71B | $3.82B |
Volume | 1,680,425 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $159.93 | $20.75 |
52-Week Low | $38.14 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $10.40B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
